| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/08/2004 | WO2003105775A3 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 04/08/2004 | WO2003105611A3 Beverages containing plant sterols |
| 04/08/2004 | WO2003104473A8 Galactosyl isomalt, method for production and use thereof |
| 04/08/2004 | WO2003100087A3 Regulation of novel human asparagine-hydroxylases |
| 04/08/2004 | WO2003100008A3 Neutralizing human anti-igfr antibody |
| 04/08/2004 | WO2003092605A9 Protease inhibitors |
| 04/08/2004 | WO2003086314A3 Tyrosine kinase inhibitors |
| 04/08/2004 | WO2003084521A3 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 04/08/2004 | WO2003083135A3 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) |
| 04/08/2004 | WO2003068140A3 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 04/08/2004 | WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 04/08/2004 | WO2003063893A3 Fgfr agonists |
| 04/08/2004 | WO2003047519A3 'compressed annular tablet with molded triturate tablet for oral and intraoral' |
| 04/08/2004 | WO2003044037A3 Process for the manufacture of human mononuclear phagocytic leukocytes |
| 04/08/2004 | WO2003035683A8 Surfactant protein-d and atherosclerosis |
| 04/08/2004 | WO2003027068A3 Substituted amines for the treatment of neurological disorders |
| 04/08/2004 | WO2003018553A8 Oral antidiabetic agents |
| 04/08/2004 | WO2003014300A3 TRPS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 04/08/2004 | WO2003012030A3 Isoform-selective inhibitors and activators of pde3 cyclic |
| 04/08/2004 | WO2003003806A3 Dye-azide compounds for dual phototherapy |
| 04/08/2004 | WO2002099074A8 Slc7s as modifiers of the p53 pathway and methods of use |
| 04/08/2004 | WO2002092008A3 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 04/08/2004 | WO2002081668A9 Desaturase genes and uses thereof |
| 04/08/2004 | WO2001087839A8 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity |
| 04/08/2004 | US20040068268 Devices and methods for the restoration of a spinal disc |
| 04/08/2004 | US20040068207 Active oxygen generator containing photosensitizer for ultrasonic therapy |
| 04/08/2004 | US20040068120 Arylated furan- and thiophenecarboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
| 04/08/2004 | US20040068109 Activated blood coagulation factor X inhibitor and also to such a pharmaceutical agent and particularly has an excellent activity by oral administration |
| 04/08/2004 | US20040068039 PVA embolic materials are prepared through saponifying poly(vinyl pivalate) |
| 04/08/2004 | US20040068015 Prevention constriction of vascular system; metalloproteinase inhibitor |
| 04/08/2004 | US20040068005 Pharmaceutical combinations |
| 04/08/2004 | US20040068002 4-aminobenzopyran derivatives |
| 04/08/2004 | US20040067999 Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
| 04/08/2004 | US20040067990 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 04/08/2004 | US20040067989 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents |
| 04/08/2004 | US20040067984 Psychological disorders; central nervous system disorders; cognition activators |
| 04/08/2004 | US20040067969 Syntheses of quinazolinones |
| 04/08/2004 | US20040067966 Adenosine receptor antagonists and methods of making and using the same |
| 04/08/2004 | US20040067959 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 04/08/2004 | US20040067955 Pyridazinone compound and pharmaceutical use thereof |
| 04/08/2004 | US20040067954 Benzoylpyridazines |
| 04/08/2004 | US20040067953 Combination therapy for treating, preventing or managing proliferative disorders and cancers |
| 04/08/2004 | US20040067949 Substituted indoles which are parp inhibitors |
| 04/08/2004 | US20040067947 Atherosclerosis; restenosis; cardiovascular disorders; immunosuppresants |
| 04/08/2004 | US20040067946 Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 04/08/2004 | US20040067945 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 04/08/2004 | US20040067944 Antiarrhythmia agents |
| 04/08/2004 | US20040067943 Tryptase inhibitors |
| 04/08/2004 | US20040067941 Central nervous system disorders; anxiolytic agents; antidepressants; antiepilepsy agents; antiarthritic agents |
| 04/08/2004 | US20040067940 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease |
| 04/08/2004 | US20040067937 Guanylate cyclase stimulant; cardiovascular disorders; thrombosis; antiischemic agents; sexual disorders; antiinflammatory agents; central nervous system disorders |
| 04/08/2004 | US20040067933 Prevent bile acid transportation; antilipemic agents; anticholesterol agents |
| 04/08/2004 | US20040067918 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative |
| 04/08/2004 | US20040067916 Method for treating, inhibiting or preventing pathogenic change resulting from vascular injury with an aldosterone antagonist |
| 04/08/2004 | US20040067891 Therapeutic and/or preventive agents for diseases due to retinal ischemia |
| 04/08/2004 | US20040067553 Membrane protein for diagnosis and treatment of nervous system, endocrine, metabolic, cancer, inflamatory, respiratory, immune and infectious diseases |
| 04/08/2004 | US20040067491 Diagnosis of diseases associated with metabolism |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |
| 04/08/2004 | US20040067261 Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
| 04/08/2004 | US20040067256 Novel modified release formulation |
| 04/08/2004 | US20040067252 Novel modified release formulation |
| 04/08/2004 | US20040067237 Using a rational selection of representative PspAs from various families of clades to produce broadly efficacious Pneumococcal vaccines |
| 04/08/2004 | US20040067218 Extramedullary adipose tissue cells and use thereof for regenerating hematopoietic and muscular tissue |
| 04/08/2004 | CA2500228A1 [1,2,4]-triazolo[1,5-c]pyrimidine derivative |
| 04/08/2004 | CA2499817A1 Derivatives comprising sterols and/or stanols and specific classes of anti-inflammatory agents and use thereof in treating or preventing cardiovascular disease |
| 04/07/2004 | EP1405852A1 Diamine derivatives |
| 04/07/2004 | EP1405848A1 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
| 04/07/2004 | EP1405845A1 Method for purifying n2-(1(s)-ethoxycarbonyl-3-phenylpropyl)-n6-trifluoroacetyl-l-lysine |
| 04/07/2004 | EP1405083A2 Natural ligand of gpcr chemr23 and uses thereof |
| 04/07/2004 | EP1405082A2 Method for identifying compounds for the therapy of aging of the cardiovascular system |
| 04/07/2004 | EP1405079A2 Modulation of the interaction between evh1 domains |
| 04/07/2004 | EP1404876A2 Interferon alpha-14 polymorphism |
| 04/07/2004 | EP1404860A2 Delivery system for nucleic acids |
| 04/07/2004 | EP1404853A1 Process for the production of allicin |
| 04/07/2004 | EP1404831A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 04/07/2004 | EP1404714A2 Nuclear hormone receptor ligand binding domain |
| 04/07/2004 | EP1404703A2 G-protein coupled receptors |
| 04/07/2004 | EP1404679A2 (hetero)aryl substituted benzofurans as 5-ht ligands |
| 04/07/2004 | EP1404676A1 Pyrrolopyrimidines as protein kinase inhibitors |
| 04/07/2004 | EP1404672A1 Tyrosine kinase inhibitors |
| 04/07/2004 | EP1404667A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/07/2004 | EP1404664A1 Aminediols for the treatment of alzheimer's disease |
| 04/07/2004 | EP1404653A1 Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion |
| 04/07/2004 | EP1404650A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 04/07/2004 | EP1404649A1 New phenylalkyloxy-phenyl derivatives |
| 04/07/2004 | EP1404412A1 Treatment and composition for wound healing |
| 04/07/2004 | EP1404377A2 Improved chelator conjugates |
| 04/07/2004 | EP1404371A2 Peptide-based compounds for targeting intergin receptors |
| 04/07/2004 | EP1404359A2 Methods of treatment involving human mda-7 |
| 04/07/2004 | EP1404350A2 Proteins associated with cell growth, differentiation, and death |
| 04/07/2004 | EP1404349A1 Fat-binding polymers |
| 04/07/2004 | EP1404344A2 Bone anabolic compounds and methods of use |
| 04/07/2004 | EP1404343A2 Therapeutic combinations for the treatment of hormone deficiencies |
| 04/07/2004 | EP1404340A1 Naphtothiazine positive allosteric ampa receptor modulators (paarm) |
| 04/07/2004 | EP1404339A2 Method for treating fibrotic diseases or other indications vi |
| 04/07/2004 | EP1404337A2 QUINAZOLINE AND PYRIDO 2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
| 04/07/2004 | EP1404330A1 Substituted 8-arylquinoline pde4 inhibitors |
| 04/07/2004 | EP1404320A2 A pharmaceutical composition comprising a nicotinic receptor partial antagonist and an antiemetic agent for modulating cholinergic function |
| 04/07/2004 | EP1404317A1 5-halo-tryptamine derivatives used as ligands of the 5-ht 6? and/or 5-ht 7? serotonin receptors |
| 04/07/2004 | EP1404313A2 METHYL ANALOGS OF SIMVASTATIN AS NOVEL HMG-CoA REDUCTASE INHIBITORS |